Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bluebird-Bio
Company Monitoring Page for Bluebird-Bio
latest headlines for company on cafepharma
Kite and bluebird join forces with some cutting-edge cancer tech
Fierce Biotech
Mon, 06/22/15 - 09:28 am
Tags:
Kite Pharma
,
Bluebird Bio
,
immuno-oncology
,
HPV
Bluebird Bio Gets Wall Street Love For Drug Results
Investors.com
Tue, 06/16/15 - 09:09 am
Tags:
Bluebird Bio
,
LentiGlobin
,
sickle cell disease
Bluebird bio builds its case for gene therapy as first sickle cell patient responds
Fierce Biotech
Sat, 06/13/15 - 09:42 am
Tags:
Bluebird Bio
,
sickle cell disease
,
LentiGlobin BB305
,
gene therapy
Advisory Panel Recommends Bluebird Delay Gene Therapy Clinical Trial
TheStreet.com
Wed, 06/10/15 - 09:04 am
Tags:
Bluebird Bio
,
advisory panels
,
FDA
,
gene therapy
,
LentiGlobin
Celgene narrows pioneering CAR-T collaboration with bluebird bio, hands over $25M sweetener
Fierce Biotech
Thu, 06/4/15 - 12:04 pm
Tags:
Celgene
,
CAR-T
,
Bluebird Bio
,
bb2121
Bluebird Bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
Yahoo
Tue, 05/26/15 - 04:23 pm
Tags:
Bluebird Bio
,
Five Prime
,
R&D
,
chimeric antigen receptor T-cell immunotherapies
Bluebird beats a path to early approval for its pioneering gene therapy
Fierce Biotech
Tue, 05/19/15 - 10:43 am
Tags:
Bluebird Bio
,
gene therapy
,
LentiGlobin BB305
What You Need To Know In Biotech: An ASCO Disappointment, Big Money In Brains And A New CF Drug
Forbes
Sun, 05/17/15 - 01:56 pm
Tags:
ASCO
,
cystic fibrosis
,
neratinib
,
Puma Biotechnology
,
Bluebird Bio
,
SAGE Therapeutics
,
Orkambi
,
Vertex Pharmaceuticals
Why These 4 Biotech Stocks Could Be the Next Buyout Targets
24/7 Wall St
Thu, 05/7/15 - 09:23 am
Tags:
biotech
,
M&A
,
Biomarin
,
Bluebird Bio
,
Incyte
,
Vertex Pharmaceuticals
Could These Experimental Drugs Eclipse Harvoni's Historic Launch?
Motley Fool
Mon, 03/30/15 - 11:13 am
Tags:
drug launches
,
Bluebird Bio
,
LentiGlobin BB305
,
aducanumab
,
Biogen Idec
,
Gilead Sciences
,
Harvoni
Biotech pros' top 8 stock picks
Fortune
Mon, 03/9/15 - 11:59 am
Tags:
biotech
,
Bluebird Bio
,
Chimerix
,
Puma Biotechnology
,
Incyte
,
Isis Pharmaceuticals
,
Celgene
,
Alexion
,
Regeneron
The Next 3 Likely Biotech Buyout Candidates
24/7 Wall St
Fri, 03/6/15 - 08:38 am
Tags:
biotech
,
Biomarin
,
Bluebird Bio
,
Incyte
,
M&A
Gene therapy pioneer Bluebird bags a 'breakthrough' title for lead program
Fierce Biotech
Mon, 02/2/15 - 08:08 am
Tags:
Bluebird Bio
,
gene therapy
,
beta-thalassemia
,
LentiGlobin BB305
Safety concerns cloud early promise of powerful new cancer drugs
Yahoo/Reuters
Mon, 01/26/15 - 08:12 am
Tags:
cancer
,
CAR-T
,
Amgen
,
Celgene
,
Bluebird Bio
,
Novartis
,
Kite Pharma
,
Pfizer
,
Cellectis
,
Juno Therapeutics
After CAR-T: Getting Ahead of the Next Hot Trend in Cancer Stocks
TheStreet.com
Tue, 01/6/15 - 08:56 am
Tags:
CAR-T
,
cancer
,
Juno Therapeutics
,
Kite Pharma
,
Celgene
,
Bluebird Bio
Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015
TheStreet.com
Tue, 01/6/15 - 08:52 am
Tags:
Sanofi
,
MannKind
,
Gilead Sciences
,
Santhera
,
Puma Biotechnology
,
Bluebird Bio
,
Celgene
,
Pfizer
,
Biogen Idec
Cellectis Is Late To The CAR-T Cell Race, But Could Finish First
Seeking Alpha
Fri, 01/2/15 - 07:33 pm
Tags:
Cellectis
,
CAR-T
,
Novartis
,
GSK
,
Bellicum
,
Celgene
,
Bluebird Bio
The Best-Performing Biotechnology Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:32 pm
Tags:
biotech
,
Avanir
,
OvaScience
,
Agios
,
Bluebird Bio
,
Receptos
,
Prosensa
,
Pernix
,
Achillion
,
Amicus Therapeutics
,
CytoSorbents
,
PTC Therapeutics
The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers
24/7 Wall St
Tue, 12/30/14 - 10:20 am
Tags:
Agios Pharmaceuticals
,
OvaScience
,
Radius
,
Prosensa
,
TG Therapeutics
,
Bluebird Bio
,
Receptos
Best and worst 2014 biotech performers on Wall Street
Fierce Biotech
Tue, 12/23/14 - 10:24 am
Tags:
Avanir Pharmaceuticals
,
Agios Pharmaceuticals
,
TG Therapeutics
,
Bluebird Bio
,
Vivus
,
Agerion
,
Theravance
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.